Search
for
Sort by
Research 30 of 336
- GLP-1 Receptor Analogs: Evidence Linking to Effect on Metabolic and Reproductive Functions in Patients with PCOS and Obesity
- Diagnosis, Management, and Associated Comorbidities of Polycystic Ovary Syndrome: A Narrative Review
- Peptide Therapy in Aesthetic, Metabolic, and Endocrine Medicine
- Hair Loss Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Use: A Systematic Review
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
- “From evidence to practice” – Insights from the multidisciplinary team on the optimal integration of GLP‐1 receptor agonists in obesity management services
- Associations Between GLP‐1 Receptor Agonists and Alopecia: A Multi‐Centre Retrospective Analysis and Public Interest Trends
- GLP-1 RAs and Skin Health: Exploring Dermatologic Side Effects and Therapeutic Interventions
- Effects of Glucagon-like Peptide-1 Receptor Agonists on Skin Homeostasis and Skin Aging Processes
- Improvement of Recalcitrant Folliculitis Decalvans With Tirzepatide: A Case Report
- Management of Hirsutism and Acne in Women with Polycystic Ovary Syndrome: A Narrative Review of Current Evidence and Emerging Therapies
- Endocrinologia e Medicina Estética Ed. X
- Semaglutide and the Skin: An Overview of Current Evidence
- The Impact of Glucagon-like Peptide-1 Receptor Agonists on Erectile Function: Friend or Foe?
- Non-Hormonal Treatment Options for Regulation of Menstrual Cycle in Adolescents with PCOS
- THE VICIOUS CYCLE OF POLYCYSTIC OVARY SYNDROME AND BINGE EATING DISORDER: A REVIEW OF METABOLIC, PSYCHOLOGICAL, AND IATROGENIC PATHWAYS
- Impact of Reducing Obesity in PCOS: Methods and Treatment Outcomes
- Women with PCOS have a heightened risk of cardiometabolic and cardiovascular diseases: statement from the Experts Group on Inositol in Basic and Clinical Research and PCOS (EGOI-PCOS) and Italian Association of Hospital Cardiologists (ANMCO)
- Dermatological adverse reactions and therapeutic potential of semaglutide, liraglutide and tirzepatide: Analysis of UK pharmacovigilance data and literature review
- The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome
- Selected abstracts from the 47th meeting of the Irish Endocrine Society Sligo, 24th & 25th November 2023
- Farmácia Avenida Brasil, Porto
- Dercum Disease: Exploratory Therapeutic Approaches in the Absence of Standardized Medical Treatment—A Single Center Case Series
- Semaglutide-Induced Atypical Pustular Drug Eruption: A Case Report
- current possible treatment approaches of Polycystic Ovary Syndrome (PCOS)
- Farmácia da Cruz, Porto e Serviços Farmacêuticos do Hospital General Universitario Gregorio Marañón, Espanha
- Computational Drug Repositioning in Cardiorenal Disease: Opportunities, Challenges, and Approaches
- Skin manifestations of hyperandrogenism: an update
- Stem Cells and the Niche: A Dynamic Duo